GENE ONLINE|News &
Opinion
Blog

2021-10-21| Asia-Pacific

The 8 Companies Propelling Taiwan’s Biopharma Industry

by Joy Lin
Share To
In the world of biotech and pharma, the promise of high returns comes hand in hand with high risks, but that’s hardly surprising. Most companies have to equip themselves with the know-how and technology to get a foothold in the international market.

At the same time, they must grapple with high development costs and lengthy trials. When one considers Taiwan's limited resources, few companies stand out, but those do bear outstanding resumes with the potential to challenge international competitors. 

From the pool of biotechs and pharmas in Taiwan, we handpick 8 noteworthy companies based on their clinical progress and overseas achievements. Among them, some have even made big breakthroughs in treatments for cancer, AIDS, and Alzheimer's disease.

Others have a polished track record as a vaccine developer or an international contract development and manufacturing organization (CDMO). Through this article, you will be able to quickly understand what's trending in Taiwan's biotech scene.

GO Prime with only $1.49 now

LATEST
Blueprint Medicines Gathers Up To $1.25 Billion in Loans and Investments for Research and Development
2022-07-01
FDA Halts Sanofi’s $3.7B Multiple Sclerosis Investment
2022-07-01
Takeda Reveals Positive Data on Takhzyro at EAACI
2022-07-01
Bon Natural Life Limited Announces Change to Board Composition
2022-06-30
These Pharma Companies Are Laying Off Employees Due to Restructuring
2022-06-30
US Bio-Entrepreneur Program Launches in the UK
2022-06-30
ReCode Therapeutics’ Secures an Extra $120 Million To Support Its Drug Delivery Platform
2022-06-30
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top